Found: 6
Select item for more details and to access through your institution.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
- By:
- Publication type:
- Article
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3585, doi. 10.1007/s00277-024-05828-3
- By:
- Publication type:
- Article
Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 119, doi. 10.3390/cancers14010119
- By:
- Publication type:
- Article
CML-271: Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S332, doi. 10.1016/S2152-2650(21)01777-8
- By:
- Publication type:
- Article
Poster: CML-271: Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01417-8
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia is Associated with Increased Neutrophil Extracellular Trap Formation that is Augmented by Ponatinib–A Potential Contributor to Vascular Toxicity?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S292, doi. 10.1016/j.clml.2019.07.239
- By:
- Publication type:
- Article